(Reuters Health) – Increased availability of potent marijuana products in France may be driving an increase in emergency room visits by intoxicated toddlers, a new study suggests. Yearly admissions for accidental marijuana intoxication at pediatric emergency departments in France more …
Read More »Tag Archives: reuters.com
Marijuana use holds three-fold blood pressure death risk: study
LONDON (Reuters) – People who smoke marijuana have a three times greater risk of dying from hypertension, or high blood pressure, than those who have never used the drug, scientists said on Wednesday. The risk grows with every year of …
Read More »Tiny biotech firm offers Big Tobacco model to curb its nicotine habit
LONDON (Reuters) – Investors are betting on a little-known biotech company to supply Big Tobacco with low-nicotine cigarettes, but so far its technology is unproven. Shares in New York-based 22nd Century Group have soared 80 percent to a three-year high …
Read More »Zynerba’s cannabis based gel for epilepsy fails study
(Reuters) – Zynerba Pharmaceuticals said on Monday its experimental synthetic cannabis-based gel failed to induce a statistically significant reduction in seizures in a mid-stage study involving epilepsy patients. Zynerba’s ZYN002 gel is being studied in adults who have epilepsy with …
Read More »Toxic waste from U.S. pot farms alarms experts
WEAVERVILLE, Calif. (Reuters) – Pollution from illegal marijuana farms deep in California’s national forests is far worse than previously thought, and has turned thousands of acres into waste dumps so toxic that simply touching plants has landed law enforcement officers …
Read More »Q&A: Canada tries trading marijuana in new ETF
NEW YORK (Reuters) – You can smoke it or eat it, and now in Canada, you can trade it in your stock portfolio. The $120 million Horizons Marijuana Life Sciences ETF (HMMJ.TO) – the first exchange traded fund in North …
Read More »League considering working with NFLPA on marijuana study
(The Sports Xchange) – The NFL has reached out to the NFL Players’ Association in hopes of joining its study of using marijuana as a potential pain management tool for the league’s ailing players, according to The Washington Post. The …
Read More »High hopes ride on marijuana painkillers amid opioid crisis | Reuters
Two U.S. studies differ over effects of marijuana on drivers | Reuters
GW to file cannabis drug as journal confirms epilepsy success | Reuters
LONDON GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.GW first reported in March 2016 that Epidiolex cut monthly convulsive seizures by 39 percent in children with Dravet syndrome, but full results of the 120-patient study were only published in the New England Journal of Medicine on Wednesday.The journal article also showed that 5 percent of patients stopped having seizures altogether and 43 percent saw their seizures cut by half.